This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Fondazione Telethon. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Marianthi Karali: Innovator in Retinal Dystrophy Treatment
Introduction
Marianthi Karali is a prominent inventor based in Naples, Italy. She has made significant contributions to the field of medical research, particularly in the treatment of retinal dystrophies. Her innovative work focuses on the use of microRNAs in therapeutic applications.
Latest Patents
Marianthi Karali holds a patent for her invention titled "MiR-204 and miR-211 and uses thereof." This patent relates to an agent capable of increasing the level of one or more miRNAs in cells, specifically targeting the sequence UUCCCUU. The invention aims to treat and prevent retinal dystrophy characterized by photoreceptor degeneration. The patent also includes relative pharmaceutical compositions, nucleic acids, vectors, and host cells.
Career Highlights
Karali is affiliated with Fondazione Telethon, where she continues her research and development efforts. Her work has garnered attention for its potential impact on treating retinal diseases, showcasing her dedication to advancing medical science.
Collaborations
Some of her notable coworkers include Sandro Banfi and Enrico Maria Surace, who contribute to her research initiatives and collaborative projects.
Conclusion
Marianthi Karali's innovative work in the field of retinal dystrophy treatment exemplifies her commitment to improving patient outcomes through scientific research. Her contributions are paving the way for new therapeutic approaches in ophthalmology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile